| 000 | 01563 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517024018.0 | ||
| 264 | 0 | _c20160108 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1768-3254 | ||
| 024 | 7 |
_a10.1016/j.ejmech.2015.03.053 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Guo-Hai | |
| 245 | 0 | 0 |
_aDistinct novel quinazolinone exhibits selective inhibition in MGC-803 cancer cells by dictating mutant p53 function. _h[electronic resource] |
| 260 |
_bEuropean journal of medicinal chemistry _cMay 2015 |
||
| 300 |
_a377-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylation _xdrug effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Size _xdrug effects |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 2 _xmetabolism |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aQuinazolinones _xchemistry |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aXue, Wen-Bin | |
| 700 | 1 | _aAn, Yun-Feng | |
| 700 | 1 | _aYuan, Jing-Mei | |
| 700 | 1 | _aQin, Jiang-Ke | |
| 700 | 1 | _aPan, Cheng-Xue | |
| 700 | 1 | _aSu, Gui-Fa | |
| 773 | 0 |
_tEuropean journal of medicinal chemistry _gvol. 95 _gp. 377-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejmech.2015.03.053 _zAvailable from publisher's website |
| 999 |
_c24761492 _d24761492 |
||